1. Benzodiazepine consumption in Spain

   • P. Rayón
   • D. Montero
   • F. J. De Abajo

   Letter to the Editors 17 February 2009 Pages: 321 - 323

2. Drug prescription in diabetic patients in Stockholm in 1992 and 1995 – change over time

   • P. E. Wändell
   • B. Brorsson
   • H. Åberg

   PHARMACOEPIDEMIOLOGY AND DISPOSITION Pages: 249 - 254

3. Improving utilization of intravenous immune globulin through concurrent use of an indication form

   • H. H. Frayha
   • S. J. Nuessle
   • M. S. Bazarbashi

   PHARMACODYNAMICS Pages: 255 - 260

4. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler

   • A. Grahnén
   • B. Jansson
   • S.-Å. Eckernäs

   PHARMACODYNAMICS Pages: 261 - 267

5. Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis

   • C. Hoebe
   • J. de Munter
   • C. Thijs

   PHARMACODYNAMICS Pages: 269 - 275

6. Effects of calcitriol on eosinophil activity and antibody responses in patients with schistosomiasis

   • J. R. Snyman
   • K. De. Sommers
   • D. J. Lizamore

   PHARMACODYNAMICS Pages: 277 - 280

7. Effect of exogenous female sex-steroid hormones on β2-adrenoceptors in healthy males

   • K. S. Tan
   • L. C. McFarlane
   • B. J. Lipworth

   PHARMACODYNAMICS Pages: 281 - 283

8. Single-dose pharmacokinetics of paracetamol and its conjugates in Chinese non-insulin-dependent diabetic patients with renal impairment

   • M. T. V. Chan
   • P. J. Anderson
   • J. A. J. H. Critchley

   PHARMACOKINETICS AND DISPOSITION Pages: 285 - 288

9. Pharmacokinetics of nicardipine enantiomers in healthy young volunteers

   • N. Inotsume
   • T. Iwaoka
   • S. Higuchi

   PHARMACOKINETICS Pages: 289 - 292

10. Involvement of multiple cytochrome P450 isoforms in naproxen O-demethylation

    • T. S. Tracy
    • C. Marra
    • K. R. Korzekwa

    PHARMACOKINETICS AND DISPOSITION Pages: 293 - 298

11. Chloroquine blood concentrations and malaria prophylaxis in Tanzanian women during the second and third trimesters of pregnancy

    • A. Y. Massele
    • C. Kilewo
    • L. L. Gustafsson

    PHARMACOKINETICS AND DISPOSITION Pages: 299 - 305

12. Pharmacokinetics and bioavailability of oral and intramuscular artemether

    • J. Karbwang
    • K. Na-Bangchang
    • A. Thanavibul

    PHARMACOKINETICS AND DISPOSITION Pages: 307 - 310

13. The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice

    • C. P. Clifford
    • D. A. Adams
    • D. S. Davies

    PHARMACOKINETICS AND DISPOSITION Pages: 311 - 315